doi: 10.1161/01.CIR.0000145143.19711.78
(Circulation. 2004;110:2747-2771.)
© 2004 American Heart Association, Inc.
AHA Scientific Statement |
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
Background— Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in 
15% to 25% of untreated children and may lead to ischemic heart disease or sudden death.
Methods and Results— A multidisciplinary committee of experts was convened to revise the American Heart Association recommendations for diagnosis, treatment, and long-term management of Kawasaki disease. The writing group proposes a new algorithm to aid clinicians in deciding which children with fever for 
5 days and 
4 classic criteria should undergo echocardiography, receive intravenous gamma globulin (IVIG) treatment, or both for Kawasaki disease. The writing group reviews the available data regarding the initial treatment for children with acute Kawasaki disease, as well for those who have persistent or recrudescent fever despite initial therapy with IVIG, including IVIG retreatment and treatment with corticosteroids, tumor necrosis factor-
antagonists, and abciximab. Long-term management of patients with Kawasaki disease is tailored to the degree of coronary involvement; recommendations regarding antiplatelet and anticoagulant therapy, physical activity, follow-up assessment, and the appropriate diagnostic procedures to evaluate cardiac disease are classified according to risk strata.
Conclusions— Recommendations for the initial evaluation, treatment in the acute phase, and long-term management of patients with Kawasaki disease are intended to assist physicians in understanding the range of acceptable approaches for caring for patients with Kawasaki disease. The ultimate decisions for case management must be made by physicians in light of the particular conditions presented by individual patients.
Key Words: AHA Scientific Statements • vasculitis • aneurysm • diagnosis • therapy
This article has been cited by other articles:
 |
|
 |
|
  J. Sullivan and N. Amarshi Dual antiplatelet therapy with clopidogrel and aspirin Am. J. Health Syst. Pharm., June 15, 2008; 65(12): 1134 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Codispoti, S. Boyd, D. Sees, and W. Conner Symptomatic Coronary Obstruction Due to Kawasaki Disease in an Adult Ann. Thorac. Surg., March 1, 2008; 85(3): 1081 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Furukawa, M Kishiro, K Akimoto, S Nagata, T Shimizu, and Y Yamashiro Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease Arch. Dis. Child., February 1, 2008; 93(2): 142 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Minich, L. A. Sleeper, A. M. Atz, B. W. McCrindle, M. Lu, S. D. Colan, B. F. Printz, G. L. Klein, R. P. Sundel, M. Takahashi, et al. Delayed Diagnosis of Kawasaki Disease: What Are the Risk Factors? Pediatrics, December 1, 2007; 120(6): e1434 - e1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Miyake, K. Gauvreau, L. Y. Tani, R. P. Sundel, and J. W. Newburger Characteristics of Children Discharged From Hospitals in the United States in 2000 With the Diagnosis of Acute Rheumatic Fever Pediatrics, September 1, 2007; 120(3): 503 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Knockaert Cardiac involvement in systemic inflammatory diseases Eur. Heart J., August 1, 2007; 28(15): 1797 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Z. Gazit, J. N. Avari, D. T. Balzer, and E. K. Rhee Electrocardiographic Diagnosis of Myocardial Ischemia in Children: Is a Diagnostic Electrocardiogram Always Diagnostic? Pediatrics, August 1, 2007; 120(2): 440 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Slosberg and C. G. Smith Jr, Esquir The Importance of Disclaimers: Distinction Between Optimal Care and Standard of Care Pediatrics, August 1, 2007; 120(2): 453 - 455. [Full Text] [PDF]
|
|
|
|
|
|
B. W. McCrindle, J. S. Li, L. L. Minich, S. D. Colan, A. M. Atz, M. Takahashi, V. L. Vetter, W. M. Gersony, P. D. Mitchell, J. W. Newburger, et al. Coronary Artery Involvement in Children With Kawasaki Disease: Risk Factors From Analysis of Serial Normalized Measurements Circulation, July 10, 2007; 116(2): 174 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Burns The Riddle of Kawasaki Disease N. Engl. J. Med., February 15, 2007; 356(7): 659 - 661. [Full Text] [PDF]
|
|
|
|
|
|
J. W. Newburger, L. A. Sleeper, B. W. McCrindle, L. L. Minich, W. Gersony, V. L. Vetter, A. M. Atz, J. S. Li, M. Takahashi, A. L. Baker, et al. Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease N. Engl. J. Med., February 15, 2007; 356(7): 663 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF]
|
|
|
|
|
|
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics Circulation, December 12, 2006; 114(24): 2710 - 2738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Falcini, L. Ricci, G. M. Poggi, G. Simonini, G. B. Calabri, and M. de Martino Severe cutaneous manifestations in a child with refractory Kawasaki disease Rheumatology, November 1, 2006; 45(11): 1444 - 1445. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Burns S100 Proteins in the Pathogenesis of Kawasaki Disease J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1265 - 1267. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Z. Baer, L. G. Rubin, C. A. Shapiro, S. K. Sood, S. Rajan, Y. Shapir, A. Romano, and F. Z. Bierman Prevalence of Coronary Artery Lesions on the Initial Echocardiogram in Kawasaki Syndrome Arch Pediatr Adolesc Med, July 1, 2006; 160(7): 686 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Stagi, G. Simonini, L. Ricci, M. de Martino, and F. Falcini Coeliac disease in patients with Kawasaki disease. Is there a link? Rheumatology, July 1, 2006; 45(7): 847 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kobayashi, Y. Inoue, K. Takeuchi, Y. Okada, K. Tamura, T. Tomomasa, T. Kobayashi, and A. Morikawa Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease Circulation, June 6, 2006; 113(22): 2606 - 2612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Hui-Yuen, T. T. Duong, and R. S. M. Yeung TNF-{alpha} Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease J. Immunol., May 15, 2006; 176(10): 6294 - 6301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Gandhi and D G Wilson Incomplete Kawasaki disease: not to be forgotten. Arch. Dis. Child., March 1, 2006; 91(3): 276 - 277. [Full Text] [PDF]
|
|
|
|
|
|
T. Thom, N. Haase, W. Rosamond, V. J. Howard, J. Rumsfeld, T. Manolio, Z.-J. Zheng, K. Flegal, C. O'Donnell, S. Kittner, et al. Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 14, 2006; 113(6): e85 - e151. [Full Text] [PDF]
|
|
|
|
|
|
M. E. Rosenkranz, D. J. Schulte, L. M.A. Agle, M. H. Wong, W. Zhang, L. Ivashkiv, T. M. Doherty, M. C. Fishbein, T. J.A. Lehman, K. S. Michelsen, et al. TLR2 and MyD88 Contribute to Lactobacillus casei Extract-Induced Focal Coronary Arteritis in a Mouse Model of Kawasaki Disease Circulation, November 8, 2005; 112(19): 2966 - 2973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dergun, A. Kao, S. B. Hauger, J. W. Newburger, and J. C. Burns Familial Occurrence of Kawasaki Syndrome in North America Arch Pediatr Adolesc Med, September 1, 2005; 159(9): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Sinha and T Balakumar BCG reactivation: a useful diagnostic tool even for incomplete Kawasaki disease Arch. Dis. Child., September 1, 2005; 90(9): 891 - 891. [Full Text] [PDF]
|
|
|
|
|
|
T. P. Graham Jr, D. J. Driscoll, W. M. Gersony, J. W. Newburger, A. Rocchini, and J. A. Towbin Task Force 2: Congenital heart disease J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1326 - 1333. [Full Text] [PDF]
|
|
|
|
 |
|
 Kawasaki Disease: New Information About Diagnosis, Management, and Treatment Journal Watch Pediatrics and Adolescent Medicine, January 14, 2005; 2005(114): 17 - 17. [Full Text]
|
|